At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Hyaluronandietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Human Pilot Study - HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement for Promoting Intestinal Health
In Brief
A clinical study evaluating Hyaluronan for Gastrointestinal Microbiome. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate whether oral HA35 supplementation changes the normal intestinal bacteria, increases intestinal protection, decrease intestinal inflammation and permeability, and to assess any health benefits and confirm the safety profile of HA35.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastrointestinal Microbiome
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJul 2016
First PostedAug 2016
Primary CompletionSep 2017
Study CompletionJun 2019
TodayJul 2026
First PostedAug 16, 2016
Enrollment StartJul 1, 2016
Primary CompletionSep 20, 2017
Study CompletionJun 20, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.9 years ago
Interventions
Hyaluronandietary